Botanical Solution Inc. (BSI) Series A Extended to Over $23 Million
Funding to accelerate scalable commercial production of pharmaceutical grade QS-21 for human vaccines, R&D lab expansion, opening new markets for vaccine developers. August 20, 2024 12:14 PM Pacific Daylight Time DAVIS, Calif.–(BUSINESS WIRE)–Today, Botanical Solution…